Featured Insights

  1. Preparing For Change: Rare Disease Launches In The Era Of EU Health Technology Assessment (HTA) 5/9/2025

    Experts at Pharma 2025 discussed the impending EU Health Technology Assessment and its implications for rare disease product launches, highlighting key challenges and necessary organizational adaptations for the pharmaceutical industry.

  2. Harnessing AI: Revolutionizing Drug Discovery And Early Disease Detection 5/9/2025

    The power of data and algorithms is unlocking new frontiers in healthcare. Pharma 2025 discussions focused on AI's role in revolutionizing drug discovery and early detection.

  3. Navigating The Evolution Of EU Health Technology Assessment (HTA) Regulation 5/9/2025

    The future of pharmaceutical access in Europe is being shaped by the new EU HTA regulation. Insights from Pharma 2025, featuring Herbert Altmann and Alexander Natz, shed light on this pivotal shift.

  4. Exploring Payer Coverage Of Anti-Obesity Medications 4/14/2025

    Understanding payer strategies for anti-obesity drugs is crucial. A recent study investigated commercial formulary trends, confirming cost as a major barrier despite positive patient outcomes.

  5. Exploring Value-Based Contracting In Rare Diseases 4/14/2025

    How are payers using value-based contracts for costly rare disease therapies? Exploratory research sheds light on negotiation frequency, preferred contract types, and internal data management trends.

  6. 5 Questions On Exploring Healthcare Decision-Maker Sentiments 4/14/2025

    Research presented at AMCP 2025 uses natural language processing on decision-maker feedback to predict coverage. Learn about the surprising findings and next steps in this Q&A.

  7. Scientific Literature Reviews And AI's Potential For Evidence Synthesis 4/14/2025

    Scientific literature reviews are crucial for HEOR decision-making but notoriously slow. Explore how AI can potentially accelerate evidence synthesis while maintaining necessary scientific rigor.

  8. Key Takeaways From The ISPE Aseptic Processing Seminar 4/14/2025

    How is the pharmaceutical industry increasing aseptic processing safety? An ISPE event showcased innovations like robotics and improved risk management, aligning with recent regulatory guidance.

  9. Essential Guide To Post-Approval Regulatory Lifecycle Maintenance 4/14/2025

    Learn about the growing trend of regulatory affairs outsourcing in pharma, driven by R&D growth and the need for specialized expertise to manage product lifecycles effectively.

  10. The Advantages Of Pharmacovigilance Outsourcing At The Local Level 4/14/2025

    Outsourcing pharmacovigilance tasks can free up local teams for strategic work. Learn how to build effective partnerships by aligning needs, understanding capabilities, and fostering collaboration.